Therapeutic Advances in Musculoskeletal Disease
Published by SAGE
ISSN : 1759-720X eISSN : 1759-7218
Abbreviation : Ther. Adv. Musculoskelet. Dis.
Aims & Scope
Therapeutic Advances in Musculoskeletal Disease delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of osteoporosis and rheumatic diseases such as rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis and other related musculoskeletal diseases.
The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in rheumatology, osteoporosis and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The journal publishes review articles, original research articles, meta-analyses, systematic reviews, editorials, case reports, case series and letters to the Editor primarily.
Original research manuscripts may include laboratory, animal or human/clinical studies - all phases.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 4.1 |
| 2024 | 3.40 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.348 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 54 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 2903 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 1113 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,650.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations
Citation: 865
Authors: Jeremy, Christin M.
-
Aging and bone loss: new insights for the clinician
Citation: 439
Authors: Oddom, Christopher, Gustavo
-
Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis
Citation: 359
Authors: Mary B.
-
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
Citation: 351
Authors: Bente, Serge, David W.
-
The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis
Citation: 300
Authors: Srinivasan, Ernest H.
-
Wnt signaling in bone formation and its therapeutic potential for bone diseases
Citation: 296
Authors: Jeong Hwan, Xing, Jinhua, Xiang, Hongyu, Stephanie H., Jing, Ruidong, Wenwen, Yuhan, Jiye, Wei, Joseph, Mary Rose, Chen, Ning, Prashant, Justin, Joseph, Ningning, Hue H., Rex C., Tong-Chuan
-
Alterations in periarticular bone and cross talk between subchondral bone and articular cartilage in osteoarthritis
Citation: 162
Authors: Steven R.
-
Chondroitin sulfate in the treatment of osteoarthritis: from <i>in vitro</i> studies to clinical recommendations
Citation: 155
Authors: Yves, Mariane, Christelle, Cecile
-
Effectiveness of intra-articular therapies in osteoarthritis: a literature review
Citation: 141
Authors: Peter, Christopher, Jana, William